Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1

Immunity

Volumn 40, Issue 6, 2014, Pages 961-973

  Crouse, Josh ^a   Bedenikovic, Gregor ^a   Wiesel, Melanie ^a,g   Ibberson, Mark ^b   Xenarios, Ioannis ^b   VonLaer, Dorothee ^c   Kalinke, Ulrich ^d   Vivier, Eric ^e   Jonjic, Stipan ^f   Oxenius, Annette ^a  

^a ETH ZURICH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e INSERM   (France)

^f UNIVERSITY OF RIJEKA   (Croatia)

^g NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROTECTION; CELL SELECTION; CELL SURVIVAL; EFFECTOR CELL; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HOMOZYGOSITY; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MICROARRAY ANALYSIS; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, LY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; IMMUNITY, INNATE; INTERFERON TYPE I; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PERFORIN; RECEPTOR, INTERFERON ALPHA-BETA; RHABDOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; VESICULOVIRUS; VIRUS REPLICATION;

EID: 84902654063     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.05.003     Document Type: Article

References (44)

1. Agarwal P., Raghavan A., Nandiwada S.L., Curtsinger J.M., Bohjanen P.R., Mueller D.L., Mescher M.F. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 Tcell effector function and memory. J.Immunol. 2009, 183:1695-1704.
2. Aichele P., Unsoeld H., Koschella M., Schweier O., Kalinke U., Vucikuja S. CD8 Tcells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J.Immunol. 2006, 176:4525-4529.
3. Andrews D.M., Estcourt M.J., Andoniou C.E., Wikstrom M.E., Khong A., Voigt V., Fleming P., Tabarias H., Hill G.R., van der Most R.G., et al. Innate immunity defines the capacity of antiviral Tcells to limit persistent infection. J.Exp. Med. 2010, 207:1333-1343.
4. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
5. Biron C.A., Sonnenfeld G., Welsh R.M. Interferon induces natural killer cell blastogenesis invivo. J.Leukoc. Biol. 1984, 35:31-37.
6. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., Cantoni C., Grassi J., Marcenaro S., Reymond N., et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J.Exp. Med. 2003, 198:557-567.
7. Carayannopoulos L.N., Naidenko O.V., Fremont D.H., Yokoyama W.M. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J.Immunol. 2002, 169:4079-4083.
8. Cerwenka A., Lanier L.L. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 2001, 181:158-169.
9. Cook K.D., Whitmire J.K. The depletion of NK cells prevents Tcell exhaustion to efficiently control disseminating virus infection. J.Immunol. 2013, 190:641-649.
10. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., Mescher M.F. Type I IFNs provide a third signal to CD8 Tcells to stimulate clonal expansion and differentiation. J.Immunol. 2005, 174:4465-4469.
11. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., Moretta A., Moretta L. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 2003, 33:2410-2418.
12. French A.R., Yokoyama W.M. Natural killer cells and viral infections. Curr. Opin. Immunol. 2003, 15:45-51.
13. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006, 7:517-523.
14. Gidlund M., Orn A., Wigzell H., Senik A., Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 1978, 273:759-761.
15. Havenar-Daughton C., Kolumam G.A., Murali-Krishna K. Cutting Edge: The direct action of type I IFN on CD4 Tcells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J.Immunol. 2006, 176:3315-3319.
16. Hayakawa Y., Screpanti V., Yagita H., Grandien A., Ljunggren H.G., Smyth M.J., Chambers B.J. NK cell TRAIL eliminates immature dendritic cells invivo and limits dendritic cell vaccination efficacy. J.Immunol. 2004, 172:123-129.
17. Iizuka K., Naidenko O.V., Plougastel B.F., Fremont D.H., Yokoyama W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 2003, 4:801-807.
18. Kägi D., Ledermann B., Bürki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., Hengartner H. Cytotoxicity mediated by Tcells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369:31-37.
19. Kamphuis E., Junt T., Waibler Z., Forster R., Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 2006, 108:3253-3261.
20. Keppler S.J., Aichele P. Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen. Eur. J. Immunol. 2011, 41:3176-3186.
21. Keppler S.J., Theil K., Vucikuja S., Aichele P. Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) Tcells. Eur. J. Immunol. 2009, 39:1774-1783.
22. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., Murali-Krishna K. Type I interferons act directly on CD8 Tcells to allow clonal expansion and memory formation in response to viral infection. J.Exp. Med. 2005, 202:637-650.
23. Lang P.A., Lang K.S., Xu H.C., Grusdat M., Parish I.A., Recher M., Elford A.R., Dhanji S., Shaabani N., Tran C.W., et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. USA 2012, 109:1210-1215.
24. Lu L., Ikizawa K., Hu D., Werneck M.B., Wucherpfennig K.W., Cantor H. Regulation of activated CD4+ Tcells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007, 26:593-604.
25. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060.
26. Marrack P., Kappler J., Mitchell T. Type I interferons keep activated Tcells alive. J.Exp. Med. 1999, 189:521-530.
27. Narni-Mancinelli E., Chaix J., Fenis A., Kerdiles Y.M., Yessaad N., Reynders A., Gregoire C., Luche H., Ugolini S., Tomasello E., et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl. Acad. Sci. USA 2011, 108:18324-18329.
28. Narni-Mancinelli E., Jaeger B.N., Bernat C., Fenis A., Kung S., De Gassart A., Mahmood S., Gut M., Heath S.C., Estellé J., et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates Tcell responses. Science 2012, 335:344-348.
29. Nattermann J., Feldmann G., Ahlenstiel G., Langhans B., Sauerbruch T., Spengler U. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2006, 55:869-877.
30. Oxenius A., Bachmann M.F., Zinkernagel R.M., Hengartner H. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 1998, 28:390-400.
31. Pace K.E., Hahn H.P., Pang M., Nguyen J.T., Baum L.G. CD7 delivers a pro-apoptotic signal during galectin-1-induced Tcell death. J.Immunol. 2000, 165:2331-2334.
32. Pircher H., Moskophidis D., Rohrer U., Bürki K., Hengartner H., Zinkernagel R.M. Viral escape by selection of cytotoxic Tcell-resistant virus variants invivo. Nature 1990, 346:629-633.
33. Sarkar S., Kalia V., Haining W.N., Konieczny B.T., Subramaniam S., Ahmed R. Functional and genomic profiling of effector CD8 Tcell subsets with distinct memory fates. J.Exp. Med. 2008, 205:625-640.
34. Schluns K.S., Lefrançois L. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 2003, 3:269-279.
35. Shiratori I., Ogasawara K., Saito T., Lanier L.L., Arase H. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J.Exp. Med. 2004, 199:525-533.
36. Soderquest K., Walzer T., Zafirova B., Klavinskis L.S., Polić B., Vivier E., Lord G.M., Martín-Fontecha A. Cutting edge: CD8+ Tcell priming in the absence of NK cells leads to enhanced memory responses. J.Immunol. 2011, 186:3304-3308.
37. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
38. Waggoner S.N., Taniguchi R.T., Mathew P.A., Kumar V., Welsh R.M. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ Tcells, leading to prolonged viral persistence and altered pathogenesis. J.Clin. Invest. 2010, 120:1925-1938.
39. Waggoner S.N., Cornberg M., Selin L.K., Welsh R.M. Natural killer cells act as rheostats modulating antiviral Tcells. Nature 2012, 481:394-398.
40. Waggoner S.N., Daniels K.A., Welsh R.M. Therapeutic depletion of natural killer cells controls persistent infection. J.Virol. 2014, 88:1953-1960.
41. Wiesel M., Kratky W., Oxenius A. Type I IFN substitutes for Tcell help during viral infections. J.Immunol. 2011, 186:754-763.
42. Wiesel M., Crouse J., Bedenikovic G., Sutherland A., Joller N., Oxenius A. Type-I IFN drives the differentiation of short-lived effector CD8+ Tcells invivo. Eur. J. Immunol. 2012, 42:320-329.
43. Wu J., Lanier L.L. Natural killer cells and cancer. Adv. Cancer Res. 2003, 90:127-156.
44. Yokoyama W.M. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc. Natl. Acad. Sci. USA 1995, 92:3081-3085.